Share
Source: AP Photo/John Minchillo
Pfizer released some rather welcoming news on Wednesday, which Cortney reported on, that the Pfizer clinical trials on children aged 12-15 was 100 percent effective.
A press release from Pfizer noted that The companies plan to submit these data to the FDA and EMA for a requested amendment to the Emergency Use Authorization of BNT162b2 and that there also is an ongoing study in children aged 6 months-11 years. The 5 to 11 year-old cohort started dosing last week and the companies plan to initiate the 2 to 5 year-old cohort next week, the press release read.
Again, this is welcoming news. If you re worried it will give the teachers